Variant sequences: the new frontier in sequence IP

A variant sequence is typically a naturally-occurring molecule, most frequently protein, which has been modified in order to impart desired characteristics such as improved stability under anticipated use conditions, or increased activity. Optimising sequences and, of course, the associated IP rights, span most areas of biotechnology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents

12 February 2026 The court has denied a German non-practising entity’s bid to secure unitary protection for a patent that it has asserted against Intel.

Careers

Honigman bags second Kirkland litigator this year for IP team

12 February 2026 New Bloomfield Hills partner handles patent, trade secrets, and contracts disputes, and marks the sixth partner to join the firm in 2026.

Europe

Reaction: Emotional Perception decision is ‘good for UK PLC’

12 February 2026 UK and European patent attorneys share their initial views after the UK Supreme Court delivered its landmark judgment, which “brings some much‑needed clarity and consistency” to the patentability of AI-related innovations—including those in the medtech industry.

More features

The curtain closes on three major drug disputes

Novartis takes aim at Tafinlar generic in latest suit

Fed Circ overturns PTAB decision in $83.4m DNA case

Novartis win blocks generics relitigating $7.8bn heart drug patent

Rooted in rights: Lessons from plant patent infringement and invalidity cases

Skinny labels, big stakes: SCOTUS lines up the case of the year

Speciality pharma firm stumbles on bid to enforce Belbuca ruling

Senior USPTO solicitor steps into private practice

Variant sequences: the new frontier in sequence IP

More on this story

Editor's picks

Editor's picks

More features